Examining Both Sides of the Sirtuin Coin

Sirtuins hold promise as a therapeutic target for a variety of neurodegenerative diseases. This piece discusses the history and efforts of Sirtris and Elixir Pharmaceuticals to develop activators and inhibitors of SIRT1, which one study has shown to be upregulated in an animal model of ALS.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail